Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.

Inokuchi, K

Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow. [electronic resource] - Leukemia & lymphoma May 1998 - 553-61 p. digital

Publication Type: Comparative Study; Journal Article

1042-8194

10.3109/10428199809050915 doi


Core Binding Factor Alpha 2 Subunit
DNA, Neoplasm--analysis
Disease-Free Survival
Flow Cytometry
Humans
Immunophenotyping
Killer Cells, Natural--pathology
Leukemia, Myeloid, Acute--genetics
Leukemia, Promyelocytic, Acute--genetics
Neoplasm Proteins--analysis
Neoplasm, Residual
Oncogene Proteins, Fusion--analysis
Polymerase Chain Reaction
Predictive Value of Tests
RUNX1 Translocation Partner 1 Protein
Recombinant Fusion Proteins--analysis
Remission Induction
T-Lymphocyte Subsets--pathology
Time Factors
Transcription Factors--analysis